J&J to pay more to settle suits over hip implants
Its DePuy unit agrees to extend deadline for new settlements over defective devices, pushing total compensation to US$3b
Delaware
JOHNSON & Johnson agreed to pay as much as US$420 million more to resolve lawsuits over recalled hip implants that were excluded in 2013 from a US$2.5 billion settlement of claims that the devices were defective and caused metal poisoning in patients.
J&J's DePuy unit agreed to push back the deadline for recipients of the company's ASR implants to file settlement claims to Jan 31 of this year, according to a filing Friday in federal court in Toledo, Ohio. That will allow as many as 1,400 patients who've had ASR hips removed since 2013 to seek about US$300,000 each in compensation under the original 2013 accord.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue